Hamilton, New Zealand

Rohit Jain

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer New Zealand Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rohit Jain. Retrieved from https://idiyas.com/inventor/rohit-jain-716q1tzj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Rohit Jain: Pioneering Injectable Antibiotic Formulations

Introduction

Rohit Jain is an innovative inventor based in Hamilton, New Zealand, who has made a significant contribution to the field of pharmaceuticals. His work focuses on developing injectable antibiotic formulations that aim to improve patient outcomes in antibiotic delivery.

Latest Patents

Rohit holds one patent, which is centered around "Injectable antibiotic formulations and their methods of use." This invention features a composition that includes penethamate (PNT) or a pharmaceutical equivalent, along with at least one oily vehicle. This advancement is crucial for enhancing the efficacy and administration of antibiotics.

Career Highlights

Rohit is currently employed at Bayer New Zealand Limited, a reputable company dedicated to health and well-being. His role in the organization allows him to explore and realize his innovative ideas, making a positive impact in the medical field.

Collaborations

As part of his professional journey, Rohit collaborates with notable colleagues such as Fadil Al Alawi and Olaf Bork. These partnerships foster a dynamic environment for innovation and development in pharmaceutical research.

Conclusion

Rohit Jain’s commitment to advancing injectable antibiotic formulations is a testament to his role as a crucial innovator in the pharmaceutical industry. His patent reflects his dedication to improving healthcare solutions and his collaboration with esteemed professionals enhances the possibility of future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…